CLL Topics Banner: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
CLL Topics Home Navigation Topics Alert Learning Tools About Us Feedback Feedback
Full Menu

Topics Alert

  • el
  • pt
  • world balloon

    Topics Alert Archive

    Locate Any Alert by Title or Number

    library stacks

    Announcing: CLL Topics Updates

    • As of January 1, 2024 the CLL Topics Alerts service has been discontinued.
    • Please visit CLL Topics Updates, our new interactive web site, to read about all the latest research, clinical trials and best practices – timely information that can make all the difference.
    • These Archives of past Topics Alerts will continue to be available.

    Updated: December 20, 2024

    This database of Alerts is updated periodically, usually once a month. The most recent Alert issued is # 310 while the most recent one archived here is # 309. Recently issued Alerts will make it here, eventually. If you would like to receive the Alerts in the form of emails as they are issued, you may register at our Alert Subscription page.

    NOTICE: This database contains the text of messages originally sent as emails to subscribers of Topics Alert, a free service of CLL Topics Inc. The content of this database is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.

    To read any of the Alerts listed below, simply click on the title of your choice anywhere in the list.

    You may also enter the Alert number in the box below and click "Display".
    Please restrict your entry to a number actually listed here, in the range between 1 and 309.

    Enter Alert Number Here to Retrieve Alert        

    Listing of Alerts

      #      Date              Title

    309 Dec 18, 2024 Acupuncture

    308 Dec 06, 2024 Toxoplasmosis (Cat Lovers - Beware!)

    307 Dec 02, 2024 Take Care of your Ticker

    306 Nov 20, 2024 Pneumonia - the Alpha and Omega for CLL Patients

    305 Nov 07, 2024 Familial CLL

    304 Nov 03, 2024 ITP: It Really Helps to Get Rid of the Bugs in Your Stomach

    303 Nov 01, 2024 MGUS: Not So Benign After All

    302 Oct 28, 2024 Fighting Two Wars at the Same Time

    301 Oct 27, 2024 Campath in the News

    300 Oct 09, 2024 Double Trouble : More is Not Better When it Comes to 13q Deletions

    299 Oct 09, 2024 A New "Superbug" to Torment Us

    298 Sep 29, 2024 A Good Day to Talk about Depression

    297 Sep 27, 2024 Two New Clinical Trials With HuMax-CD20

    296 Sep 24, 2024 Dirty Lab Coats: Doctors Who Compromise Patients' Health

    295 Sep 22, 2024 Tanning Beds? Not Even if You Are a Republican!

    294 Sep 21, 2024 A New Anti-CD20 Monoclonal in Clinical Trials

    293 Sep 13, 2024 Rituxan in the news

    292 Sep 06, 2024 Revlimid (aka lenalidomide) in the news

    291 Aug 04, 2024 The physician - patient relationship

    290 Jul 31, 2024 Humax-CD20 clinical trial results

    289 Jul 28, 2024 NK Cell Therapy: Better Than Transplants?

    288 Jul 25, 2024 At last! Some one did the Rituxan experiment that needed to be done

    287 Jul 09, 2024 Warning: Cipro, Levaquin may cause serious tendon damage

    286 Jul 04, 2024 Do Not Go Gentle Into That Good Night

    285 Apr 25, 2024 Mantle Cell Lymphoma and Lyme disease

    283 Mar 31, 2024 Low hemoglobin and platelets: the WHY is important

    281 Mar 08, 2024 Rituxan + Fenretinide Clinical Trial Update

    280 Mar 04, 2024 Does prior Rituxan therapy take away "chemo naive" status?

    279 Mar 02, 2024 Are CLL patients living longer?

    277 Feb 25, 2024 A Bold New Journey Starts

    276 Feb 19, 2024 CLL - Work in Progress

    275 Feb 12, 2024 The flu bug is particularly nasty this year

    274 Feb 10, 2024 Single agent fludarabine: Don't do it

    273 Jan 18, 2024 Mini-allo MUD transplants at the NCI

    272 Jan 16, 2024 A Great Man Has Died

    271 Jan 12, 2024 Hearing Patients' Voices

    270 Jan 05, 2024 EPO Drugs - Not to Be Overused

    269 Dec 23, 2024 Keep Your Money Where It Is Most Needed

    268 Dec 20, 2024 CT Scans: Are They Necessary to Evaluate Response to Therapy?

    267 Dec 20, 2024 Genitope's MyVax Disappoints

    266 Dec 13, 2024 Treanda: A Facelift for Bendamustine

    265 Dec 07, 2024 Flu Season: Prevention, Prevention and More Prevention …

    264 Dec 06, 2024 ITP: Immune Thrombocytopenia

    262 Nov 27, 2024 Green Tea - Phase I Trial Results at Mayo Clinic

    261 Nov 25, 2024 Secondary Cancers in CLL

    260 Nov 17, 2024 Tell It Like It Is, Please

    259 Nov 16, 2024 HuMax-CD20 Clinical Trial Results

    258 Nov 12, 2024 Genitope CLL Vaccine Trial Update

    257 Oct 16, 2024 Ground Rules

    256 Oct 14, 2024 Grim News for Refractory Patients

    255 Oct 08, 2024 Dithering Is Human

    254 Oct 07, 2024 Jab & Dab: Clinical Trial Launched

    253 Sep 29, 2024 Quality of Life with CLL

    252 Sep 24, 2024 Campath as Frontline Therapy

    251 Sep 19, 2024 The Best and Worst of American Medicine

    250 Sep 10, 2024 Making Sensible Decisions About Stem Cell Transplants

    248 Sep 01, 2024 Call to Action

    247 Aug 29, 2024 FISHing in Murky Waters

    246 Aug 17, 2024 What You Don't Know Can Hurt You

    245 Aug 15, 2024 Prophylaxis: Do It Right — Take the Necessary Precautions Ahead of Time

    244 Aug 12, 2024 With a Little Help from a Million or So of Your Friends

    243 Aug 10, 2024 Cord Blood Transplants: The State of the Art

    242 Aug 08, 2024 Gene Therapies

    241 Jul 14, 2024 Lyme Disease and CLL

    240 Jul 05, 2024 Autoimmune Complications

    239 Jul 04, 2024 Catch 22: The Transplant Minefield

    238 Jun 12, 2024 Harvey's Battle Plans

    237 Jun 08, 2024 Got Protection? Immunoglobulins

    236 Jun 08, 2024 Secondary Cancers in CLL & What You Can Do to Protect Yourself

    235 May 27, 2024 “Vaccine Therapy” Clinical Trial at Baylor

    234 May 26, 2024 FUO: Fevers of Unknown Origin

    233 May 16, 2024 Bexxar: An Introduction to Radioimmunotherapy

    232 May 11, 2024 Rituxan: Delayed Onset Neutropenia

    231 May 07, 2024 Protecting the Borders

    230 May 04, 2024 Mini-allo Transplants Just Got Safer

    229 Apr 29, 2024 Tumor Load, Lactic Acid, Cramps and Infections

    228 Apr 22, 2024 Refractory AIHA: What Comes After Steroids and Rituxan?

    227 Apr 12, 2024 CAT-8015 Clinical Trial

    226 Apr 05, 2024 How Old Is “Old”?

    225 Apr 01, 2024 Treating Autoimmune Disease: ITP and AIHA in CLL

    224 Mar 28, 2024 Conflict of Interest Can Kill

    223 Mar 25, 2024 AIHA and FCR Therapy

    222 Mar 09, 2024 FDA Gets Serious about EPO Warning

    221 Mar 06, 2024 This Year's Flu

    220 Mar 06, 2024 “Lumi” — The New Babe in Town

    219 Mar 04, 2024 Using Revlimid Outside Clinical Trials

    218 Jan 30, 2024 Revlimid Phase II Results at ASH 2024

    217 Jan 27, 2024 Therapy Induced Pulmonary Toxicity

    216 Jan 25, 2024 Two Flu Shots Better than One?

    215 Jan 21, 2024 Curry and Spice and All Things Nice (?!)

    214 Jan 20, 2024 Steroid Therapy and Potential Diseases of the Eye

    213 Jan 08, 2024 Rituxan + Fenretinide: A Brand New Clinical Trial Sponsored by CLL Topics

    212 Jan 06, 2024 More on Stem Cell Transplants — Almost Free

    211 Jan 03, 2024 Sibling Donor Stem Cell Transplants - Almost Free

    207 Nov 30, 2024 Toxicity and "Chemo Brain"

    206 Nov 28, 2024 Credible Information on Vitamin D3 — The Vitamin D Council

    205 Nov 27, 2024 Women Donors for Stem Cell Transplants

    204 Nov 24, 2024 Vitamin D3 and Infections

    203 Nov 18, 2024 Easy Does It — Questioning the Gold Standard

    202 Nov 17, 2024 Bronchitis: Don't Reach for the Antibiotics

    201 Nov 16, 2024 Epoetin: Money Makes the World Go Around

    200 Nov 16, 2024 Tregs Revealed: Regulators and Killers

    199 Nov 13, 2024 Familial CLL: New Developments

    198 Nov 08, 2024 Respiratory Infections

    196 Sep 19, 2024 Management of Early Stage, Newly Diagnosed Patients

    193 Sep 02, 2024 Illusions: I Have CLL but I Never Get Sick

    192 Sep 02, 2024 Infections: Who Is Most at Risk?

    191 Aug 31, 2024 Steroid-Campath Combinations: A Sledgehammer To Be Used Wisely

    190 Aug 30, 2024 News Report: Drug companies "manipulating trials"

    189 Aug 26, 2024 Rituxan: the Shaving Reaction

    188 Aug 24, 2024 CLL: Diagnosis and Treatment — Overview Article

    187 Aug 21, 2024 MRSA: A Deadly Super Bug

    186 Aug 16, 2024 Vitamin D3 Debate Continues

    184 Aug 12, 2024 HuMax-CD20: Belt, Suspenders — and Cummerbund

    183 Aug 12, 2024 Usefulness of Online Medical Information

    182 Aug 02, 2024 CLL Topics in the News

    181 Aug 01, 2024 Genitope Vaccine Trial: Developments

    180 Jul 31, 2024 CLL and Risk of Lung Cancer

    179 Jul 28, 2024 A Bullseye on Rituxan

    178 Jul 26, 2024 Bird Flu (H5N1): Some Hopeful News

    177 Jul 22, 2024 Doxorubicin: the Gift that Keeps on Giving

    176 Jul 22, 2024 Pushing Revlimid

    175 Jul 21, 2024 Simvastatin, EBV-Driven Lymphomas, Patents

    174 Jul 20, 2024 David vs. Goliath - Comparing HuMax-CD20 with Rituxan

    173 Jul 14, 2024 Filtering Out EBV Noise

    172 Jul 08, 2024 Mononucleosis and CLL: a Straw Poll

    171 Jul 05, 2024 EBV: The Enemy Within

    170 Jun 20, 2024 Quality of Life with CLL

    169 Jun 18, 2024 CLL and Skin Cancers: How to "Sell" Your Doctors

    168 Jun 16, 2024 Summer Is Here — and So Are Skin Cancer Worries

    167 Jun 10, 2024 Infections Kill CLL Patients

    166 Jun 07, 2024 Safety Concerns: Epogen, Procrit, Aranesp

    165 Jun 05, 2024 How Did We Get Here From There?

    164 May 26, 2024 Harvey is Back! An Update on Genmab's HuMax-CD20

    163 May 26, 2024 Project Alpha Update

    162 May 26, 2024 Transparency in Clinical Trials: Your Life Depends on It

    161 May 18, 2024 Money Makes the World Go Round

    160 May 14, 2024 Jab & Dab

    159 Apr 10, 2024 An Update on Harvey

    158 Apr 04, 2024 Stem Cell Transplants: Are You a Good Candidate?

    157 Mar 22, 2024 Honor Is Due

    156 Mar 22, 2024 CLL, the "Chronic Condition"?

    155 Mar 19, 2024 F+C vs F Comparison

    154 Mar 15, 2024 Thalidomide in Blood Cancers: Disappointing Results

    153 Mar 05, 2024 A Vaccine Trial for CLL Patients

    152 Feb 26, 2024 Forest Bump

    151 Feb 16, 2024 Aranesp Safety Warning

    150 Jan 31, 2024 Rituxan Adverse Effects

    149 Feb 09, 2024 CLL Therapy: Winning the Battle but Losing the War?

    148 Feb 07, 2024 Green Tea Extracts (EGCG) and Weight Loss

    147 Feb 06, 2024 Latest on Green Tea Extracts (EGCG)

    146 Jan 23, 2024 Lymphocyte Doubling Time

    145 Jan 18, 2024 Comparing Apples and Kumquats

    144 Jan 12, 2024 FCR Lite — The Goldilocks Dilemma

    143 Jan 06, 2024 RF Risks and Benefits

    142 Jan 03, 2024 Early Results from GenMab's HuMax Clinical Trial

    141 Dec 14, 2024 Omega-3 Fats in Fish Oil Combat Pulmonary Inflammation

    140 Dec 09, 2024 EGCG: Early Clinical Results in CLL Patients

    139 Dec 09, 2024 Suspension of 17-AAG Clinical Trial

    137 Nov 17, 2024 Avian Flu and CLL

    136 Nov 11, 2024 FISH, "Normal" Karyotype, and Clonal Evolution

    135 Nov 09, 2024 MCL - a Wolf in CLL Clothing

    134 Nov 02, 2024 Three New CLL Clinical Trials - All Targeting Bcl-2

    133 Oct 19, 2024 Familial CLL: a Reminder

    132 Oct 11, 2024 F versus FC

    131 Sep 29, 2024 Mayo Website Article on Bird Flu

    129 Sep 28, 2024 Bird Flu in Humans

    128 Sep 24, 2024 The Big Business of Clinical Trials

    127 Sep 22, 2024 Things that Go Bump in the Night: The Flu Season Is Upon Us

    126 Sep 16, 2024 New Improved CD20 Monoclonal from Genmab

    125 Sep 08, 2024 Skin Cancer Worries: Useful Contact Information

    124 Sep 07, 2024 Novel Immunotherapy Trial at the Hutch

    123 Aug 22, 2024 Project Alpha Begins Patient Recruitment

    122 Aug 19, 2024 The Brit. Version of FCR+M

    121 Aug 17, 2024 Death by Conventional Wisdom

    120 Aug 12, 2024 Dr. Faderl's Response

    119 Aug 11, 2024 A Turbocharged Clinical Trial: FCR+M

    118 Aug 10, 2024 Balancing Risks and Rewards: FCR+M Clinical Trial

    117 Aug 09, 2024 FRC, Kicked Up Another Notch!

    116 Aug 06, 2024 What to Avoid in Stem Cell Transplants

    115 Aug 04, 2024 A Statin a Day

    114 Aug 01, 2024 Risk Adapted Strategies

    113 Aug 01, 2024 Genmab's HuMax-CD20 Clinical Trial

    112 Jul 29, 2024 GVHD in Allo Stem Cell Transplants

    111 Jul 27, 2024 Medscape Review: Epidemic of Skin Cancers

    110 Jul 26, 2024 Nice to See the Good Guys Win

    109 Jul 19, 2024 The Only Real Cure Out There, for Now

    108 Jul 19, 2024 Fludarabine Therapy Increases Risk of Skin Cancer

    107 Jul 17, 2024 An Interesting Vaccine Trial for CLL Patients

    106 Jul 16, 2024 A New Lease on Life for "Bucket C" Patients

    105 Jul 14, 2024 Special Care for Your Heart

    104 Jun 24, 2024 17-AAG: A Brand New Clinical Trial

    103 Jun 22, 2024 G-CSF or GM-CSF? Which Is the Safer Choice?

    102 Jun 21, 2024 Rituxan plus Leukine (GM-CSF) Has Benefit in NHL

    101 Jun 21, 2024 IgVH Test, Quest, Ohio State

    100 Jun 20, 2024 Telling It Like It Is

    99 Jun 09, 2024 Interview with Honokiol Researchers

    98 May 08, 2024 Don't Waste Your Money

    97 May 26, 2024 Fludarabine: Risk of Richter’s Transformation

    96 May 23, 2024 Revlimid: A Breakthrough?!?

    95 May 21, 2024 A Morality Tale of Two Friends

    94 May 16, 2024 Buddy Can You Spare a Little Blood to Get this Research Going?

    92 May 08, 2024 Honokiol: Miracle Herb or Feel Happy Pill?

    91 Apr 21, 2024 Benefits of IVIg: Worth Examining

    90 Apr 21, 2024 Aldara: a Promising New Drug for Actinic Keratosis

    88 Apr 20, 2024 More on Prognostic Test Packages - Take Care of the Details

    87 Apr 03, 2024 Affordable Prognostic Testing - Now Available at Last!

    86 Mar 18, 2024 CLL Global Research Foundation

    85 Mar 16, 2024 The Dangers of Vitamin E Supplements

    84 Mar 13, 2024 Rituxan plus Short Duration Campath

    83 Mar 06, 2024 Good News for the Tough Cases - Campath to the Rescue

    82 Feb 26, 2024 Who Is Driving the Bus?

    81 Feb 25, 2024 The Dawn of a New Era

    80 Feb 23, 2024 Anemia Can Be a Silent Killer

    79 Feb 19, 2024 Project Alpha Fundraising Goal Reached

    78 Feb 17, 2024 Inquiring Minds: This Might Be Good for a Chuckle or Two

    77 Feb 16, 2024 The Difference Is Friendliness

    76 Feb 10, 2024 Progress on Prognostics

    75 Feb 04, 2024 Genitope: Vaccine Approach to B-Cell Cancers

    74 Jan 31, 2024 More on Mouth Sores: An Expert Weighs In

    73 Jan 30, 2024 Oral Sores Can Get Pretty Ugly

    72 Jan 28, 2024 Dr. Hamblin Speaks Out

    71 Jan 23, 2024 A Fishy Tale

    70 Jan 21, 2024 Aranesp Warning – The Dark Side of Epo

    69 Jan 12, 2024 A Real Pain in the Mouth

    68 Dec 23, 2024 "Harvey" Is Doing Well

    67 Dec 23, 2024 Remicade Warning

    66 Dec 20, 2024 An Early Christmas Present from Blood

    65 Dec 20, 2024 Gifts From the Heart

    64 Dec 18, 2024 Matching Made Simple

    63 Dec 17, 2024 Vioxx Gone - Now Celebrex Is Out Too

    62 Dec 12, 2024 ASH 2024 Highlights

    61 Dec 11, 2024 EGCG Candy - Just in Time for the Holiday Season

    60 Dec 08, 2024 Squamous Cell Carcinoma

    59 Nov 27, 2024 Genes Sleeping on the Job

    57 Nov 16, 2024 R plus HDPM

    56 Nov 11, 2024 How Much EGCG Should You Take?

    55 Nov 09, 2024 Shopping for the Right Therapy

    54 Oct 26, 2024 CDC Advisory on Anti-virals in Response to Flu Vaccine Shortage

    53 Oct 25, 2024 Cancer Drugs, Wheelchairs on Medicare's Cutback List

    51 Oct 15, 2024 New Rituxan Combination in the News

    49 Oct 11, 2024 Rituxan Warning

    48 Oct 09, 2024 Vioxx Is Out but How About Celebrex?

    47 Oct 05, 2024 Those Pesky Aches and Pains

    46 Oct 04, 2024 A Derivative of Celebrex as Potential CLL Drug

    45 Oct 01, 2024 Vioxx Warning

    44 Sep 29, 2024 Exciting New Drugs on the CLL Horizon

    42 Sep 15, 2024 CLL and Basal Cell Carcinoma

    41 Sep 14, 2024 ZAP-70 and IgVH Gene Mutation Status as Prognostic Indicators

    40 Sep 02, 2024 "Teavigo": Roche's High EGCG Content Product

    39 Aug 24, 2024 Mayo Best Practices

    38 Aug 15, 2024 AIHA: Autoimmune Hemolytic Anemia

    34 Jul 30, 2024 Clinical Trial Results: Rituxan + Campath

    32 Jul 15, 2024 New York Times editorial on July 14, "Choosing Death"

    31 Jul 14, 2024 Familial CLL: An Expert Opinion

    30 Jul 06, 2024 Adding Neupogen to Rituxan Therapy

    29 Jun 30, 2024 FluCam-106

    28 Jun 25, 2024 Project Alpha Milestones

    27 Jun 24, 2024 The Dangers of Overmedication

    26 Jun 15, 2024 "Coral Calcium"

    25 Jun 15, 2024 The Flip Side of Sun Avoidance – Too Little Vitamin D3

    24 Jun 06, 2024 Flavopiridol - a Drug that May Save Lives

    22 May 13, 2024 Fludarabine Monotherapy No Longer the Gold Standard

    21 May 12, 2024 Corticosteroid Therapy and Increased Risk of Skin Cancer

    18 May 06, 2024 More on "Harvey’s Chocolates"

    17 May 04, 2024 Harvey’s Chocolates

    16 Apr 30, 2024 Bone Loss after Stem Cell Transplants

    15 Apr 20, 2024 Familial CLL

    14 Apr 18, 2024 Hitting a Home Run with Campath Consolidation?

    13 Mar 15, 2024 Results of Phase - 2 Ontak in Relapsed CLL Patients

    12 Apr 13, 2024 LMB-2 in Phase - II Trial Sponsored by NCI

    11 Apr 13, 2024 Combination of Rituxan plus Campath in Relapsed CLL Patients

    10 Apr 08, 2024 Is Rituxan More Dangerous Than Fludarabine?

    9 Mar 31, 2024 Comparing Clinical Trials

    8 Mar 28, 2024 Stem Cell Transplants in CLL Patients: Dana Farber Statistics

    7 Mar 26, 2024 CLL Greatly Increases Your Risk of Skin Cancer

    6 Mar 24, 2024 Fludarabine as Front-line Therapy

    5 Mar 22, 2024 Sinus and Pulmonary Problems in CLL

    4 Mar 21, 2024 ZAP-70 Testing: Where to Go, How Much It Costs

    3 Mar 20, 2024 Two Popular Anemia Drugs Under FDA Scrutiny

    2 Mar 19, 2024 Deletion of 6q21 and Prognostic Risk

    1 Mar 18, 2024 What You Need to Know – Mayo "Best Practices"

     

     

    ———

    Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.


    Copyright Notice:

    Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.

    All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.

    However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.

    ———

    crest

     

    GuideCompass
    up arrow